Global Small Animal Imaging (In-Vivo) global market 2024, Forecast To 2033

The small animal imaging (in-vivo) market has seen rapid growth, increasing from $2.59 billion in 2023 to $2.91 billion in 2024, reflecting a CAGR of 12.6% during the historical period. This growth is attributed to preclinical research and drug development, expansion in the pharmaceutical and biotechnology sectors, increased translational research, and studies on disease modeling and pathophysiology, supported by academic and government funding for research. Looking ahead to 2028, the market is expected to experience rapid growth, reaching $4.55 billion at a CAGR of 11.8%. Factors contributing to this anticipated growth include the development of novel imaging probes and tracers, the expansion of preclinical Contract Research Organizations (CROs), the integration of AI in image analysis, advanced multimodal imaging systems, 3D and high-resolution imaging for small animals, and an increased focus on research for rare and orphan diseases. Major trends in this forecasted period include molecular and functional imaging in small animals, longitudinal and real-time in-vivo imaging, the use of hybrid imaging modalities for multimodal information, imaging of CRISPR-edited animals for genetics research, AI-driven phenotyping, and biomarker discovery, as well as imaging for neurodegenerative diseases and neuroscience.